ABG
IDYA icon

Ally Bridge Group’s IDEAYA Biosciences IDYA Stock Holding History

Ally Bridge Group’s Portfolio IDYA Stock Details IDYA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-430,000
Closed -$10.2M – 22
2021
Q4 		$10.2M Sell
430,000
-145,940
-25% -$3.39M 3.55% 13
2021
Q3 		$14.7M Buy
575,940
+65,533
+13% +$1.53M 4.32% 11
2021
Q2 		$10.7M Buy
510,407
+480,407
+1,601% +$9.87M 2.66% 18
2021
Q1 		$705K Buy
+30,000
New +$579K 0.14% 32

Other funds holding IDYA

LGM
Logos Global Management San Francisco, California $2B AUM 444.09% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
CPX
Canaan Partners X Menlo Park, California $74.7M AUM 151.56% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Ally Bridge Group's IDYA Position: Q1 2022 in Review

Ally Bridge Group sold out of IDEAYA Biosciences (IDYA) in Q1 2022, closing a stake of 430,000 shares — an estimated $10.2M sold.

Ally Bridge Group first reported a position in IDYA in Q1 2021 and held it in 4 quarters. The position peaked at $14.7M in Q3 2021. 103 funds tracked by Wall St. Rank hold IDYA as of Q1 2022.

  • Ally Bridge Group reported no remaining IDEAYA Biosciences position as of Q1 2022 after selling out during the quarter.
  • Ally Bridge Group sold 430,000 IDEAYA Biosciences shares in Q1 2022, an estimated $10.2M.
  • Ally Bridge Group first reported a position in IDEAYA Biosciences in Q1 2021 and held it in 4 quarters.
  • Ally Bridge Group's IDEAYA Biosciences position peaked at $14.7M in Q3 2021.
  • 103 funds tracked by Wall St. Rank held IDEAYA Biosciences as of Q1 2022.

Based on Ally Bridge Group's 13F filing for Q1 2022, filed 16 May 2022.